MHC-I-restricted presentation of HIV-1 virion antigens without viral replication

被引:133
作者
Buseyne, F
Le Gall, S
Boccaccio, C
Abastado, JP
Lifson, JD
Arthur, LO
Rivière, Y
Heard, JM
Schwartz, O [1 ]
机构
[1] Inst Pasteur, Unite Retrovirus & Transfert Genet, Paris, France
[2] Inst Pasteur, Lab Immunopathol Virale, Paris, France
[3] Inst Cordeliers, ImmunoDesigned Mol Res Labs, Paris, France
[4] NCI, Retroviral Pathogenesis Lab, AIDS Vaccine Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
关键词
D O I
10.1038/85493
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells and macrophages can process extracellular antigens for presentation by MHC-I molecules. This exogenous pathway may have a crucial role in the activation of CD8(+) cytotoxic T lymphocytes during human viral infections. We show here that HIV-1 epitopes derived from incoming virions are presented through the exogenous MHC-I pathway in primary human dendritic cells, and to a lower extent in macrophages, leading to cytotoxic T-lymphocyte activation in the absence of viral protein synthesis. Exogenous antigen presentation required adequate virus-receptor interactions and fusion of viral and cellular membranes. These results provide new insights into how anti-HIV cytotoxic T lymphocytes can be activated and have implications for anti-HIV vaccine design.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 45 条
[31]  
ROCK KL, 1996, IMMUNOL TODAY, V17, P129
[32]   Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells [J].
Rodriguez, A ;
Regnault, A ;
Kleijmeer, M ;
Ricciardi-Castagnoli, P ;
Amigorena, S .
NATURE CELL BIOLOGY, 1999, 1 (06) :362-368
[33]  
Rossiter J C, 1992, Contemp Nurse, V1, P75
[34]   Role of cellular immunity in protection against HIV infection [J].
Rowland-Jones, S ;
Tan, RS ;
McMichael, A .
ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 :277-346
[35]   HIV-SPECIFIC CYTOTOXIC T-CELLS IN HIV-EXPOSED BUT UNINFECTED GAMBIAN WOMEN [J].
ROWLANDJONES, S ;
SUTTON, J ;
ARIYOSHI, K ;
DONG, T ;
GOTCH, F ;
MCADAM, S ;
WHITBY, D ;
SABALLY, S ;
GALLIMORE, A ;
CORRAH, T ;
TAKIGUCHI, M ;
SCHULTZ, T ;
MCMICHAEL, A ;
WHITTLE, H .
NATURE MEDICINE, 1995, 1 (01) :59-64
[36]   Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1 [J].
Schwartz, O ;
Maréchal, V ;
Friguet, B ;
Arenzana-Seisdedos, F ;
Heard, JM .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3845-3850
[37]   Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein [J].
Schwartz, O ;
Marechal, V ;
LeGall, S ;
Lemonnier, F ;
Heard, JM .
NATURE MEDICINE, 1996, 2 (03) :338-342
[38]   Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen [J].
Sigal, LJ ;
Crotty, S ;
Andino, R ;
Rock, KL .
NATURE, 1999, 398 (6722) :77-80
[39]   Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis [J].
Singh-Jasuja, H ;
Toes, REM ;
Spee, P ;
Münz, C ;
Hilf, N ;
Schoenberger, SP ;
Ricciardi-Castagnoli, P ;
Neefjes, J ;
Rammensee, HG ;
Arnold-Schild, D ;
Schild, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1965-1974
[40]   NATURALLY PROCESSED VIRAL PEPTIDES RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES ON CELLS CHRONICALLY INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
TSOMIDES, TJ ;
ALDOVINI, A ;
JOHNSON, RP ;
WALKER, BD ;
YOUNG, RA ;
EISEN, HN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1283-1293